User profiles for Niklas Baerlecken
Niklas BaerleckenVerified email at rheumapraxis-rodenkirchen.de Cited by 1093 |
Integrative analysis reveals a molecular stratification of systemic autoimmune diseases
…, D Belz, N Hunzelmann, N Baerlecken… - Arthritis & …, 2021 - Wiley Online Library
Objective Clinical heterogeneity, a hallmark of systemic autoimmune diseases, impedes
early diagnosis and effective treatment, issues that may be addressed if patients could be …
early diagnosis and effective treatment, issues that may be addressed if patients could be …
Engineering of adipose tissue by injection of human preadipocytes in fibrin
N Torio-Padron, N Baerlecken, A Momeni… - Aesthetic plastic …, 2007 - Springer
Background Despite efforts of plastic surgeons in recent years to discover new alternatives,
the techniques currently used for restoration of soft tissue defects still have disadvantages. …
the techniques currently used for restoration of soft tissue defects still have disadvantages. …
[PDF][PDF] Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis
…, KL Hupa‐Breier, P Behrendt, NT Baerlecken… - …, 2022 - Wiley Online Library
Background and Aims Detection of autoantibodies is a mainstay of diagnosing autoimmune
hepatitis (AIH). However, conventional autoantibodies for the workup of AIH lack either …
hepatitis (AIH). However, conventional autoantibodies for the workup of AIH lack either …
[HTML][HTML] Anti-CD74 antibodies have no diagnostic value in early axial spondyloarthritis: data from the spondyloarthritis caught early (SPACE) cohort
JJ de Winter, MG van de Sande, N Baerlecken… - Arthritis research & …, 2018 - Springer
Background Anti-CD74 IgG antibodies are reported to be elevated in patients with axial
spondyloarthritis (axSpA). This study assessed the diagnostic value of anti-CD74 antibodies in …
spondyloarthritis (axSpA). This study assessed the diagnostic value of anti-CD74 antibodies in …
Sensitivity and Specificity of Autoantibodies Against CD 74 in Nonradiographic Axial Spondyloarthritis
E Riechers, N Baerlecken, X Baraliakos… - Arthritis & …, 2019 - Wiley Online Library
… Baerlecken and Witte share a patent on the commercial use of antibodies against CD74.
Drs. Matthias and Schweikhard own stock or stock options in Aesku Diagnostics. …
Drs. Matthias and Schweikhard own stock or stock options in Aesku Diagnostics. …
[HTML][HTML] Added value of anti-CD74 autoantibodies in axial spondyloarthritis in a population with low HLA-B27 prevalence
…, I Mallak, G Merheb, P Ghorra, N Baerlecken… - Frontiers in …, 2019 - frontiersin.org
Axial spondyloarthritis (axSpA) is often diagnosed late due to the non-specific nature of its
main symptom [chronic back pain (CBP)] and to the paucity of diagnostic markers, particularly …
main symptom [chronic back pain (CBP)] and to the paucity of diagnostic markers, particularly …
Evaluation of RAG1 mutations in an adult with combined immunodeficiency and progressive multifocal leukoencephalopathy
C Schröder, NT Baerlecken, U Pannicke, T Dörk… - Clinical …, 2017 - Elsevier
Here we describe novel mutations in recombination activation gene 1 (RAG1) in a compound
heterozygous male patient with combined T and B cell immunodeficiency (CID). Clinical …
heterozygous male patient with combined T and B cell immunodeficiency (CID). Clinical …
Expression quantitative trait locus analysis in systemic sclerosis identifies new candidate genes associated with multiple aspects of disease pathology
…, D Belz, T Witte, N Baerlecken… - Arthritis & …, 2021 - Wiley Online Library
Objective To identify the genetic variants that affect gene expression (expression
quantitative trait loci [eQTLs]) in systemic sclerosis (SSc) and to investigate their role in the …
quantitative trait loci [eQTLs]) in systemic sclerosis (SSc) and to investigate their role in the …
Gain-of-function STAT1 mutations are associated with intracranial aneurysms
…, AC Jirmo, Ö Yildiz, F Donnerstag, NT Baerlecken… - Clinical …, 2017 - Elsevier
Chronic mucocutaneous candidiasis, characterized by persistent or recurrent fungal infections,
represents the clinical hallmark in gain-of-function (GOF) signal transducer and activator …
represents the clinical hallmark in gain-of-function (GOF) signal transducer and activator …
Combined anti‐Ro52/TRIM21 and anti‐Ro60/SSA antibodies are associated with increased Sjögren's disease severity through interferon pathway activation
…, D Belz, T Witte, N Baerlecken… - Arthritis & …, 2023 - Wiley Online Library
Objective The biological diagnosis of primary Sjögren's disease (SjD) mainly relies on anti‐Ro60/SSA
antibodies, while the significance of anti‐Ro52/TRIM21 antibodies currently …
antibodies, while the significance of anti‐Ro52/TRIM21 antibodies currently …